Integra LifeSciences Holdings Revenue 2010-2024 | IART

Integra LifeSciences Holdings revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Integra LifeSciences Holdings Annual Revenue
(Millions of US $)
2023 $1,542
2022 $1,558
2021 $1,542
2020 $1,372
2019 $1,518
2018 $1,472
2017 $1,188
2016 $992
2015 $883
2014 $797
2013 $697
2012 $831
2011 $780
2010 $732
2009 $682
Integra LifeSciences Holdings Quarterly Revenue
(Millions of US $)
2024-03-31 $369
2023-12-31 $397
2023-09-30 $382
2023-06-30 $381
2023-03-31 $381
2022-12-31 $398
2022-09-30 $385
2022-06-30 $398
2022-03-31 $377
2021-12-31 $406
2021-09-30 $387
2021-06-30 $390
2021-03-31 $360
2020-12-31 $389
2020-09-30 $370
2020-06-30 $259
2020-03-31 $354
2019-12-31 $395
2019-09-30 $379
2019-06-30 $384
2019-03-31 $360
2018-12-31 $383
2018-09-30 $366
2018-06-30 $366
2018-03-31 $357
2017-12-31 $369
2017-09-30 $279
2017-06-30 $282
2017-03-31 $259
2016-12-31 $256
2016-09-30 $250
2016-06-30 $249
2016-03-31 $237
2015-12-31 $241
2015-09-30 $226
2015-06-30 $213
2015-03-31 $203
2014-12-31 $153
2014-09-30 $198
2014-06-30 $231
2014-03-31 $215
2013-12-31 $81
2013-09-30 $213
2013-06-30 $206
2013-03-31 $197
2012-12-31 $214
2012-09-30 $210
2012-06-30 $210
2012-03-31 $196
2011-12-31 $204
2011-09-30 $202
2011-06-30 $193
2011-03-31 $181
2010-12-31 $194
2010-09-30 $187
2010-06-30 $179
2010-03-31 $173
2009-12-31 $184
2009-09-30 $172
2009-06-30 $166
2009-03-31 $161
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $2.170B $1.542B
Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $227.236B 27.53
Intuitive Surgical (ISRG) United States $141.461B 85.22
Edwards Lifesciences (EW) United States $53.716B 34.96
DexCom (DXCM) United States $52.240B 79.13
IDEXX Laboratories (IDXX) United States $44.882B 52.61
Alcon (ALC) Switzerland $43.802B 31.39
IQVIA Holdings (IQV) United States $42.121B 24.44
STERIS (STE) Ireland $22.993B 26.87
Waters (WAT) United States $21.115B 31.03
SONOVA HOLDING (SONVY) Switzerland $19.146B 0.00
Hologic (HOLX) United States $17.508B 19.59
Fresenius Medical Care AG KGaA (FMS) Germany $12.893B 15.05
ShockWave Medical (SWAV) United States $12.394B 77.13
Sysmex ADR (SSMXY) Japan $11.077B 34.74
Teleflex (TFX) United States $10.251B 15.96
Globus Medical (GMED) United States $8.718B 25.56
Penumbra (PEN) United States $7.890B 89.66
Masimo (MASI) United States $6.588B 37.95
Glaukos (GKOS) United States $5.530B 0.00
TransMedics (TMDX) United States $4.545B 431.19
Integer Holdings (ITGR) United States $4.051B 24.48
PROCEPT BioRobotics (PRCT) United States $3.502B 0.00
LivaNova (LIVN) United Kingdom $3.355B 19.92
Tandem Diabetes Care (TNDM) United States $3.055B 0.00
Elekta AB (EKTAY) Sweden $2.926B 20.07
Inari Medical (NARI) United States $2.660B 0.00
Nihon Kohden (NHNKY) Japan $2.485B 21.02
RxSight (RXST) United States $2.243B 0.00
Veracyte (VCYT) United States $1.749B 0.00
Alphatec Holdings (ATEC) United States $1.546B 0.00
Artivion (AORT) United States $0.978B 93.84
AVANOS MEDICAL, INC (AVNS) United States $0.936B 18.20
OPKO Health (OPK) United States $0.920B 0.00
Silk Road Medical (SILK) United States $0.875B 0.00
OrthoPediatrics (KIDS) United States $0.763B 0.00
Mesa Laboratories (MLAB) United States $0.659B 22.39
Paragon 28 (FNA) United States $0.635B 0.00
SiBone (SIBN) United States $0.615B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.563B 0.00
Pacific Biosciences Of California (PACB) United States $0.550B 0.00
IRadimed (IRMD) United States $0.532B 29.81
Pulse Biosciences (PLSE) United States $0.431B 0.00
Nevro (NVRO) United States $0.419B 0.00
Tactile Systems Technology (TCMD) United States $0.326B 11.16
Treace Medical Concepts (TMCI) United States $0.310B 0.00
Sight Sciences (SGHT) United States $0.266B 0.00
AxoGen (AXGN) United States $0.264B 0.00
EDAP TMS S.A (EDAP) France $0.249B 0.00
AngioDynamics (ANGO) United States $0.242B 0.00
908 Devices (MASS) United States $0.236B 0.00
NeuroPace (NPCE) United States $0.235B 0.00
Delcath Systems (DCTH) United States $0.210B 0.00
Inogen (INGN) United States $0.208B 0.00
Atossa Genetics (ATOS) United States $0.197B 0.00
Alpha Tau Medical (DRTS) Israel $0.197B 0.00
CVRx (CVRX) United States $0.179B 0.00
ClearPoint Neuro (CLPT) United States $0.170B 0.00
Semler Scientific (SMLR) United States $0.163B 8.25
Accuray (ARAY) United States $0.162B 0.00
Spectral Diagnostics (EDTXF) Canada $0.108B 0.00
KORU Medical Systems (KRMD) United States $0.104B 0.00
Sensus Healthcare (SRTS) United States $0.097B 20.45
Yubo Biotech (YBGJ) China $0.095B 0.00
Neuronetics (STIM) United States $0.078B 0.00
EnVVeno Medical (NVNO) United States $0.067B 0.00
Monogram Orthopaedics (MGRM) United States $0.066B 0.00
Hyperfine (HYPR) United States $0.064B 0.00
Vicarious Surgical (RBOT) United States $0.062B 0.00
Envoy Medical (COCH) United States $0.061B 0.00
InspireMD (NSPR) Israel $0.057B 0.00
DarioHealth (DRIO) United States $0.057B 0.00
SEP Acquisition (SEPA) United States $0.049B 0.00
Lucid Diagnostics (LUCD) United States $0.047B 0.00
Autonomix Medical (AMIX) United States $0.047B 0.00
LENSAR (LNSR) United States $0.047B 0.00
ReWalk Robotics (LFWD) Israel $0.044B 0.00
Precision Optics (POCI) United States $0.039B 0.00
Pixie Dust Technologies (PXDT) Japan $0.036B 0.00
Rapid Micro Biosystems (RPID) United States $0.036B 0.00
Aspira Women's Health (AWH) United States $0.033B 0.00
T2 Biosystems (TTOO) United States $0.031B 0.00
Spectral AI (MDAI) United States $0.031B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.029B 0.00
Ekso Bionics Holdings (EKSO) United States $0.025B 0.00
Accelerate Diagnostics (AXDX) United States $0.019B 0.00
QT Imaging Holdings (QTI) United States $0.019B 0.00
Biosig Technologies (BSGM) United States $0.018B 0.00
PAVmed (PAVM) United States $0.017B 0.00
NexGel (NXGL) United States $0.015B 0.00
Microbot Medical (MBOT) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.010B 0.00
Avinger (AVGR) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00